Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Organogenesis Holdings Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 150 | 2 | 132 | −16 |
| Shares | 56.0M | 345.8K | 53.3M | −2.29M (−4.1%) |
| Value | $150.6M | $928.9K | $113.8M | −$35.8M (−24.0%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Organogenesis Holdings Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 867,261 | $1.85M | 0.01% |
| Susquehanna International Group, LLP | 757,846 | $1.61M | 0.00% |
| Marshall Wace, LLP | 710,829 | $1.51M | 0.00% |
| HRT Financial LP | 357,796 | $762.0K | 0.01% |
| Ergoteles LLC | 165,565 | $352.7K | 0.01% |
| Point72 Asset Management, L.P. | 68,331 | $145.5K | 0.00% |
| Verition Fund Management LLC | 66,150 | $140.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 55,184 | $117.5K | 0.00% |
| SG Americas Securities, LLC | 29,786 | $63.0K | 0.00% |
| Tudor Investment Corp Et Al | 25,161 | $54.0K | 0.00% |
| Creative Planning | 23,119 | $49.2K | 0.00% |
| Mackenzie Financial Corp | 17,132 | $36.5K | 0.00% |
| Laurion Capital Management LP | 16,123 | $34.3K | 0.00% |
| Trivant Custom Portfolio Group, LLC | 14,593 | $31.1K | 0.02% |
| Aquatic Capital Management LLC | 13,900 | $30.0K | 0.00% |
| Caxton Associates LP | 12,306 | $26.2K | 0.00% |
| Franklin Resources Inc | 10,954 | $23.3K | 0.00% |
| Point72 Middle East FZE | 10,674 | $22.7K | 0.00% |
| Group One Trading, L.P. | 4,000 | $8.52K | 0.00% |
| Lindbrook Capital, LLC | 261 | $556 | 0.00% |
| Ameritas Advisory Services, LLC | 215 | $458 | 0.00% |
Sold out (37)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (2)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Monarch Partners Asset Management LLC | 303,681 | $816.9K |
| Comerica Bank | 42,141 | $112.0K |